What is the address of Cardioréa?

The registered office of Cardioréa is located at Rue de la Chapelle 25, 5340 Gesves.

Is Cardioréa still active?

Yes. According to the CBE (30 October 2026) Cardioréa is active, legal situation “Normale toestand”, started on 18 January 2022.

Is Cardioréa registered on Peppol?

Yes, Cardioréa is registered on the Peppol network with ID 0208:0780579289.

What is the enterprise number of Cardioréa?

The enterprise number of Cardioréa is BE0780579289.

When was Cardioréa founded?

Cardioréa was founded on 18 January 2022.

Is Cardioréa a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 18 January 2022; 4 annual accounts filed, latest fiscal year 2025.

How much profit did Cardioréa make in 2025?

Cardioréa posted a profit after taxes of € 57,110 in financial year 2025.

What is the revenue of Cardioréa?

As a small company, Cardioréa is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 135,977.

Cardioréa (Private Limited) - Gesves - BE0780579289

Dossier Cardioréa, printed on 30 October 2026 from databakkes.be/en/0780579289/cardiorea. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Tight liquidity NBB

Cash and receivables cover 25 % of short-term debt in 2025; threshold 65 %.

Financials

Financial year 2025

Cardioréa from Gesves, company number BE0780579289, closed financial year 2025 with a result of € 57,110 after tax. For that financial year Cardioréa recorded a gross margin of € 135,977 and equity of € 3,500. Compared with financial year 2024, the result moved from € 60,482 to € 57,110. The company is profitable. The buffer shrank hard: equity is 98 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on June 29, 2026.

What it is worth Shrank hard

€ 3,500

▼ 98% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 57,110

▼ 6% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 83,801

▼ 45% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 203,002 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Vehicles and equipment

€ 34,360

▼ 24% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 2 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 92,670

▼ 29% vs 2024

€ 39,933 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.

Taxes

€ 9,942

▼ 8% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 70,689 Gross margin 2022: € 70,689 First fiscal year in the series	€ 135,026 Gross margin 2023: € 135,026 ▲ 91% vs 2022 (€ 70,689) Favourable step	€ 138,304 Gross margin 2024: € 138,304 ▲ 2% vs 2023 (€ 135,026) Favourable step	€ 135,977 Gross margin 2025: € 135,977 ▼ 2% vs 2024 (€ 138,304) Unfavourable step	▼ 2%
Profit after taxes	€ 22,094 Profit after taxes 2022: € 22,094 First fiscal year in the series	€ 63,316 Profit after taxes 2023: € 63,316 ▲ 187% vs 2022 (€ 22,094) Favourable step	€ 60,482 Profit after taxes 2024: € 60,482 ▼ 4% vs 2023 (€ 63,316) Unfavourable step	€ 57,110 Profit after taxes 2025: € 57,110 ▼ 6% vs 2024 (€ 60,482) Unfavourable step	▼ 6%
Equity	€ 25,594 Equity 2022: € 25,594 First fiscal year in the series	€ 88,910 Equity 2023: € 88,910 ▲ 247% vs 2022 (€ 25,594) Favourable step	€ 149,393 Equity 2024: € 149,393 ▲ 68% vs 2023 (€ 88,910) Favourable step	€ 3,500 Equity 2025: € 3,500 ▼ 98% vs 2024 (€ 149,393) Unfavourable step	▼ 98%
Total debts	€ 429,260 Total debts 2022: € 429,260 First fiscal year in the series	€ 584,224 Total debts 2023: € 584,224 ▲ 36% vs 2022 (€ 429,260) Unfavourable step	€ 333,779 Total debts 2024: € 333,779 ▼ 43% vs 2023 (€ 584,224) Favourable step	€ 382,914 Total debts 2025: € 382,914 ▲ 15% vs 2024 (€ 333,779) Unfavourable step	▲ 15%
Cash	€ 26,717 Cash 2022: € 26,717 First fiscal year in the series	€ 241,683 Cash 2023: € 241,683 ▲ € 214,966 vs 2022 (€ 26,717) Favourable step	€ 152,524 Cash 2024: € 152,524 ▼ 37% vs 2023 (€ 241,683) Unfavourable step	€ 83,801 Cash 2025: € 83,801 ▼ 45% vs 2024 (€ 152,524) Unfavourable step	▼ 45%
Retained profit	€ 22,094 Retained profit 2022: € 22,094 First fiscal year in the series	€ 85,410 Retained profit 2023: € 85,410 ▲ 287% vs 2022 (€ 22,094) Favourable step	€ 145,893 Retained profit 2024: € 145,893 ▲ 71% vs 2023 (€ 85,410) Favourable step	€ 0 Retained profit 2025: € 0 ▼ 100% vs 2024 (€ 145,893) Unfavourable step	▼ 100%
Dividend	€ 0 Dividend 2022: € 0 First fiscal year in the series	€ 0 Dividend 2023: € 0 Unchanged (€ 0) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 203,002 Dividend 2025: € 203,002 Unchanged (€ 0) Unchanged
Bank debt	€ 0 Bank debt 2022: € 0 First fiscal year in the series	€ 168,117 Bank debt 2023: € 168,117 Unchanged (€ 0) Unfavourable step	€ 131,117 Bank debt 2024: € 131,117 ▼ 22% vs 2023 (€ 168,117) Favourable step	€ 92,670 Bank debt 2025: € 92,670 ▼ 29% vs 2024 (€ 131,117) Favourable step	▼ 29%
Balance sheet total	€ 454,854 Balance sheet total 2022: € 454,854 First fiscal year in the series	€ 673,134 Balance sheet total 2023: € 673,134 ▲ 48% vs 2022 (€ 454,854) Unchanged	€ 483,172 Balance sheet total 2024: € 483,172 ▼ 28% vs 2023 (€ 673,134) Unchanged	€ 386,414 Balance sheet total 2025: € 386,414 ▼ 20% vs 2024 (€ 483,172) Unchanged	▼ 20%

Key figures of Cardioréa, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to Cardioréa?

What happened at Cardioréa in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jun 29, 2026 New annual accounts for financial year 2025: profit of € 57,110 (▼ 6% vs 2024). Source: NBB ↗
Jan 18, 2022 New establishment in Gesves. KBO
Jan 18, 2022 Start of the company according to the CBE. KBO

In short

From € 22,094 profit in 2022 to € 57,110 profit in 2025.

Paid € 58,269 in corporate taxes since 2022.

Best year ever: 2023, with € 63,316 profit.

Paid out € 203,002 in dividends to the owners in total.

Original PDFs at the National Bank ↗

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de la Chapelle 25

5340 Gesves

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

ORTHOVAL

€ 205,089 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number: 0780.579.289
VAT number: BE 0780.579.289
Registered office: Rue de la Chapelle 25, 5340 Gesves
Names & denominations: Cardioréa
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 18 January 2022
Peppol: Active · Active since 11 Sept 2026

View on CBE Public ↗ Annual accounts (NBB) ↗

Cardioréa